ImmunityBio
Drew Crofton is a Senior Financial Analyst at ImmunityBio, Inc. since June 2022, and brings over a decade of diverse experience in accounting, finance, and operations from various companies prior to this role. Drew earned a Master of Business Administration (MBA) from Arizona State University between 2020 and 2022, following a Bachelor of Science (BS) in Accounting from Birmingham-Southern College, obtained in 2011.
This person is not in any offices
ImmunityBio
4 followers
ImmunityBio, Inc. (formerly NantKwest, Inc.) is developing cell and immunotherapy products that are designed to help strengthen each patient’s natural immune system, potentially enabling it to outsmart the disease and eliminate cancerous or infected cells.